Pharmaceutical companies have lost the right to block public comments on their company page walls. The privilege was previously granted exclusively to pharmaceutical companies who had been slow to set up company pages on the social media site.
Several companies have already closed down pages, expressing concern about the extra resources that will be required to monitor activity.
More information on this story on DailyTech.
